PL377618A1 - Benzofuranoksyetyloaminy jako czynniki antydepresyjne i anksjolityczne - Google Patents
Benzofuranoksyetyloaminy jako czynniki antydepresyjne i anksjolityczneInfo
- Publication number
- PL377618A1 PL377618A1 PL377618A PL37761804A PL377618A1 PL 377618 A1 PL377618 A1 PL 377618A1 PL 377618 A PL377618 A PL 377618A PL 37761804 A PL37761804 A PL 37761804A PL 377618 A1 PL377618 A1 PL 377618A1
- Authority
- PL
- Poland
- Prior art keywords
- drugs
- derivatives
- antidepressant
- oxyethylamines
- benzofuran
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 title 2
- 239000002249 anxiolytic agent Substances 0.000 title 1
- 230000000949 anxiolytic effect Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 239000000018 receptor agonist Substances 0.000 abstract 2
- 229940044601 receptor agonist Drugs 0.000 abstract 2
- 102000049773 5-HT2A Serotonin Receptor Human genes 0.000 abstract 1
- 108010072564 5-HT2A Serotonin Receptor Proteins 0.000 abstract 1
- 101710138068 5-hydroxytryptamine receptor 1D Proteins 0.000 abstract 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002460 anti-migrenic effect Effects 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000147 hypnotic effect Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10306941A DE10306941A1 (de) | 2003-02-18 | 2003-02-18 | Benzofuranoxyethylamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377618A1 true PL377618A1 (pl) | 2006-02-06 |
Family
ID=32748007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377618A PL377618A1 (pl) | 2003-02-18 | 2004-01-19 | Benzofuranoksyetyloaminy jako czynniki antydepresyjne i anksjolityczne |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7425574B2 (pl) |
| EP (1) | EP1594864B1 (pl) |
| JP (1) | JP4624979B2 (pl) |
| KR (1) | KR20050121200A (pl) |
| CN (1) | CN1751040A (pl) |
| AT (1) | ATE411990T1 (pl) |
| AU (1) | AU2004213097B2 (pl) |
| BR (1) | BRPI0407094A (pl) |
| CA (1) | CA2516263C (pl) |
| DE (2) | DE10306941A1 (pl) |
| ES (1) | ES2319421T3 (pl) |
| MX (1) | MXPA05008597A (pl) |
| PL (1) | PL377618A1 (pl) |
| RU (1) | RU2005128828A (pl) |
| WO (1) | WO2004074281A1 (pl) |
| ZA (1) | ZA200507436B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| NZ596889A (en) | 2006-04-07 | 2013-06-28 | Vertex Pharma | Use of amide indole derivatives as modulators of ATP-binding cassette transporters |
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| RU2745977C2 (ru) | 2010-04-22 | 2021-04-05 | Вертекс Фармасьютикалз Инкорпорейтед | Способ получения циклоалкилкарбоксамидо-индольных соединений |
| AU2013290444B2 (en) | 2012-07-16 | 2018-04-26 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| SG10201913575VA (en) | 2014-04-15 | 2020-02-27 | Vertex Pharma | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
| CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2463765A1 (fr) * | 1979-08-17 | 1981-02-27 | Clin Midy | Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire |
| US5436264A (en) * | 1993-08-19 | 1995-07-25 | Syntex (U.S.A.) Inc. | N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists |
| DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| WO1999051575A1 (en) | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents) |
| CN1160332C (zh) | 1998-04-08 | 2004-08-04 | 惠氏公司 | 用于治疗抑郁症的n-芳氧基乙基胺衍生物 |
| US6121307A (en) * | 1998-04-08 | 2000-09-19 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
| US6110956A (en) * | 1998-04-08 | 2000-08-29 | American Home Products Corp. | N-aryloxyethylamine derivatives for the treatment of depression |
| DE10112151A1 (de) | 2001-03-14 | 2002-09-19 | Merck Patent Gmbh | Substituierte Benzofuran-2-carbonsäureamide |
-
2003
- 2003-02-18 DE DE10306941A patent/DE10306941A1/de not_active Withdrawn
-
2004
- 2004-01-19 KR KR1020057015099A patent/KR20050121200A/ko not_active Withdrawn
- 2004-01-19 BR BR0407094-1A patent/BRPI0407094A/pt not_active IP Right Cessation
- 2004-01-19 CA CA2516263A patent/CA2516263C/en not_active Expired - Fee Related
- 2004-01-19 WO PCT/EP2004/000348 patent/WO2004074281A1/de not_active Ceased
- 2004-01-19 PL PL377618A patent/PL377618A1/pl unknown
- 2004-01-19 DE DE502004008315T patent/DE502004008315D1/de not_active Expired - Lifetime
- 2004-01-19 AU AU2004213097A patent/AU2004213097B2/en not_active Ceased
- 2004-01-19 EP EP04703167A patent/EP1594864B1/de not_active Expired - Lifetime
- 2004-01-19 MX MXPA05008597A patent/MXPA05008597A/es not_active Application Discontinuation
- 2004-01-19 CN CNA200480004368XA patent/CN1751040A/zh active Pending
- 2004-01-19 ES ES04703167T patent/ES2319421T3/es not_active Expired - Lifetime
- 2004-01-19 RU RU2005128828/04A patent/RU2005128828A/ru not_active Application Discontinuation
- 2004-01-19 AT AT04703167T patent/ATE411990T1/de not_active IP Right Cessation
- 2004-01-19 JP JP2006501556A patent/JP4624979B2/ja not_active Expired - Fee Related
- 2004-01-19 US US10/546,029 patent/US7425574B2/en not_active Expired - Fee Related
-
2005
- 2005-09-15 ZA ZA200507436A patent/ZA200507436B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1594864B1 (de) | 2008-10-22 |
| DE10306941A1 (de) | 2004-08-26 |
| ZA200507436B (en) | 2007-02-28 |
| CA2516263A1 (en) | 2004-09-02 |
| JP4624979B2 (ja) | 2011-02-02 |
| US7425574B2 (en) | 2008-09-16 |
| WO2004074281A8 (de) | 2005-11-17 |
| WO2004074281A1 (de) | 2004-09-02 |
| US20060084693A1 (en) | 2006-04-20 |
| JP2006517931A (ja) | 2006-08-03 |
| EP1594864A1 (de) | 2005-11-16 |
| ATE411990T1 (de) | 2008-11-15 |
| RU2005128828A (ru) | 2006-05-10 |
| CN1751040A (zh) | 2006-03-22 |
| MXPA05008597A (es) | 2005-11-04 |
| AU2004213097B2 (en) | 2010-06-24 |
| CA2516263C (en) | 2011-11-08 |
| AU2004213097A1 (en) | 2004-09-02 |
| ES2319421T3 (es) | 2009-05-07 |
| DE502004008315D1 (en) | 2008-12-04 |
| BRPI0407094A (pt) | 2006-02-07 |
| KR20050121200A (ko) | 2005-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL377618A1 (pl) | Benzofuranoksyetyloaminy jako czynniki antydepresyjne i anksjolityczne | |
| BG107171A (bg) | Производни на пурин | |
| NO20052737D0 (no) | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them. | |
| MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
| PE20061297A1 (es) | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c | |
| EA200300519A1 (ru) | Соединения производных бензотиофена, способ их получения и применения | |
| SI1910381T1 (sl) | Substituirane spojine 1-oksa-3,8-diazaspiro(4,5)-dekan-2-on in njihova uporaba za pripravo zdravil | |
| HRP20040090A2 (en) | Arylsulfonyl derivatives with 5-ht<sub>6</sub> receptor affinity | |
| DK1523486T3 (da) | Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet | |
| BR0010139A (pt) | Heterociclos bicìclicos substituìdos, processo para seu preparo e seu uso como agentes anti-obesidade e hipocolesterolêmico | |
| WO2004055026A8 (en) | Tetracyclic 3-substituted indoles having serotonin receptor affinity | |
| ATE505462T1 (de) | Neue biologischaktive molekü le | |
| CA2490115A1 (en) | Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them | |
| DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
| DE502004007318D1 (de) | Benzofuranderivate und ihre verwendung als antidepressiva und anxiolytika | |
| MA27944A1 (fr) | N-[3-(3-substituees-pyrazolo [1,5-a] pyrimidin-7-yl) - phenyl] - sulfonamides et compositions et methodes rapportees. | |
| NO20061575L (no) | Fremgangsmate for fremstilling av renzapride og mellomprodukter derav | |
| PL375259A1 (pl) | Pochodne pirydynoalkilo-aminoalkilo-1H-indolu hamujące wychwyt zwrotny 5-HT i serotoniny jako antydepresanty i anksjolityki | |
| SI1517909T1 (sl) | Novi tetraciklični arilkarbonil indoli, ki imajo afiniteto za serotoninski receptor, uporabni kot terapevtska sredstva, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo | |
| DE60116517D1 (de) | Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese | |
| SE9803155D0 (sv) | A new composition | |
| AP2001002179A0 (en) | 2-Aminocarbonyl-9h-purine derivatives. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |